6B0E image
Entry Detail
PDB ID:
6B0E
Keywords:
Title:
Crystal structure of Pfs25 in complex with the transmission blocking antibody 1260
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2017-09-14
Release Date:
2017-11-15
Method Details:
Experimental Method:
Resolution:
3.30 Å
R-Value Free:
0.28
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:1260 antibody, light chain
Chain IDs:A
Chain Length:219
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:1260 antibody, heavy chain
Chain IDs:B
Chain Length:227
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:25 kDa ookinete surface antigen
Chain IDs:C (auth: E)
Chain Length:183
Number of Molecules:1
Biological Source:Plasmodium falciparum
Ligand Molecules
Primary Citation
Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25.
Nat Commun 8 1568 1568 (2017)
PMID: 29146922 DOI: 10.1038/s41467-017-01924-3

Abstact

The Plasmodium falciparum Pfs25 protein (Pfs25) is a leading malaria transmission-blocking vaccine antigen. Pfs25 vaccination is intended to elicit antibodies that inhibit parasite development when ingested by Anopheles mosquitoes during blood meals. The Pfs25 three-dimensional structure has remained elusive, hampering a molecular understanding of its function and limiting immunogen design. We report six crystal structures of Pfs25 in complex with antibodies elicited by immunization via Pfs25 virus-like particles in human immunoglobulin loci transgenic mice. Our structural findings reveal the fine specificities associated with two distinct immunogenic sites on Pfs25. Importantly, one of these sites broadly overlaps with the epitope of the well-known 4B7 mouse antibody, which can be targeted simultaneously by antibodies that target a non-overlapping site to additively increase parasite inhibition. Our molecular characterization of inhibitory antibodies informs on the natural disposition of Pfs25 on the surface of ookinetes and provides the structural blueprints to design next-generation immunogens.

Legend

Protein

Chemical

Disease

Primary Citation of related structures